David Arkowitz - Chief Financial Officer, Flexion Therapeutics Inc

As of May 12, 2021


David Arkowitz Net Worth

  • Net worth is estimated to be at least $140.1K
  • Owns at least 220,719 units of Flexion Therapeutics Inc stock
  • Sold an estimated value of $132.58K in the last 3 years at Flexion Therapeutics Inc

David Arkowitz Trading

  • Largest purchase of shares was 4,000 units , worth over $93.68K on August 10, 2018
  • Largest sale of shares was 6,073 units , worth over $67.59K on January 7, 2021
  • In total has made about 17 transactions over 3 years
  • Usually trades in May and June, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

David Arkowitz Mailing Address

  • Mailing address is C/o Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803 MA

Flexion Therapeutics Inc Insider Trading

  • The most recent transaction was 3,945 units sold on July 20, 2021 by Christina Willwerth worth over $25.45K
  • In the last 7 years, insiders at Flexion Therapeutics Inc sold an estimated value of $36.93M and bought an estimated value of $69.1M
  • The most active traders are Michael Clayman, President and CEO,  Neil Bodick, Chief Scientific Officer,  and Samuel Colella, Director
  • Insider trading is most common in June, with the busiest year in 2021

Flexion Therapeutics Inc Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1